A business leader and management professional, Quinton Oswald is a Vero Beach resident and has played an important role in the ophthalmology industry. During his time at Novartis and Genentech , Quinton Oswald facilitated the launch of effective drugs to help those affected by wet AMD (age-related macular degeneration).He further expanded this as CEO Of Neurotech with Encapsulated Cell Therapy and Notal Vision with Home based OCT to customize patient treatment of WetAMD
Wet AMD is an eye disorder that involves blurred vision or blind spots. It is a chronic disorder that typically affects people over the age of 60. Wet AMD can cause vision impairment or distortions, difficulty reading, vision impairment in low light, lessen bright colors, and make it difficult to recognize faces. Symptoms are fluid or blood leaking from blood vessels and entering the area near the back of the eye responsible for central vision called the macula.
If Wet AMD is discovered and treated early, vision loss can be stabilized , and its possible for some vision to recover with effective treatment .. Though the cause is unknown, Wet AMD affects many people, and the likelihood of developing Wet AMD is increased by smoking, obesity, and cardiovascular disease.
Wet AMD is an eye disorder that involves blurred vision or blind spots. It is a chronic disorder that typically affects people over the age of 60. Wet AMD can cause vision impairment or distortions, difficulty reading, vision impairment in low light, lessen bright colors, and make it difficult to recognize faces. Symptoms are fluid or blood leaking from blood vessels and entering the area near the back of the eye responsible for central vision called the macula.
If Wet AMD is discovered and treated early, vision loss can be stabilized , and its possible for some vision to recover with effective treatment .. Though the cause is unknown, Wet AMD affects many people, and the likelihood of developing Wet AMD is increased by smoking, obesity, and cardiovascular disease.
